Novel cap analogs for in vitro synthesis of mRNAs with high translational efficiency

Aug 20, 2004RNA (New York, N.Y.)

New cap molecules for making mRNAs that produce proteins more efficiently in the lab

AI simplified

Abstract

The newly developed N7-benzylated dinucleoside tetraphosphate analogs exhibit up to 44-fold enhancement in translation compared to uncapped RNA.

  • Thirteen cap analogs varied by 61-fold in binding affinity to eIF4E.
  • Inhibition of cap-dependent translation ranged up to 146-fold among the analogs.
  • The efficiency of incorporation into RNAs during in vitro transcription showed a variation of 1.4-fold in % capping.
  • Orientation of the analogs in synthetic mRNA varied by 5.6-fold in % correct orientation.
  • mRNAs capped with specific analogs were translated 2.5- to 3.1-fold more efficiently than those capped with a standard cap.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free